NEW JERSEY · NAICS NAICS 6211, 6212
New Jersey medical and dental practice deals concentrate goodwill value above the threshold that triggers an independent going-concern appraisal alongside any study. Studies translate patient base, payer mix, productivity, and ramp into projections that lenders can underwrite, and reconcile relocation and build-out cost lines.
FEASIBILITY TRIGGER
Acquisitions routinely cross the $250,000 goodwill threshold triggering an independent going-concern appraisal; startups and relocations are projection-based.
From FY2010 through FY2026, New Jersey recorded 626 SBA-disbursed medical and dental practice loans across the 7(a) and 504 programs, representing $325.4 million in approved financing at an average loan size of $520,000. The state sits at rank #13 of 38 for medical and dental practice SBA lending volume and holds 1.9% of the national medical and dental practice dollar pool. 7(a) accounts for 94.2% of the count, 504 for the rest, with 104 fresh approvals dated FY2024 or later.
| Disbursed loans (FY2010–FY2026) | 626 |
| Approved volume | $325.4 million |
| Average loan size | $520,000 |
| 7(a) share | 94.2% |
| Approvals since FY2024 | 104 |
| State rank by loan count | #13 of 38 |
Among the 473 seasoned loans in this segment (approvals FY2010–FY2021), 3.8% reached adverse resolution — purchased, liquidated, or charged off. The national benchmark for medical and dental practice is 3.7%, against 7.3% across all industries. That is broadly in line with the national benchmark for this asset class.
Source: SBA 7(a) and 504 FOIA loan-level data, as of March 31, 2026. Disbursed loans only. See data methodology.
An adverse-resolution rate of 3.8%, close to the national medical and dental practice benchmark of 3.7%, puts New Jersey deals in this class on ordinary SBA credit footing. Across 626 loans averaging $520,000, the underwriting question is deal-specific: a rigorous third-party feasibility study is where documented demand and stressed coverage decide the credit outcome.
Every New Jersey medical and dental practices project we underwrite follows the same lender ready process: independent market analysis, site and technical review, and financial projections tested against SBA SOP 50 10 8 standards. Our SBA feasibility study consultants guide explains scope, timing, deliverables, and what lenders and CDCs expect in the report.
New Jersey projects most often pencil under SBA 504 because the 50/40/10 structure delivers up to 90 percent financing on owner-occupied real estate at a fixed debenture rate, which matters where North Jersey land and improvement costs run with the metro New York market. SBA 7(a) covers acquisitions, working capital, and equipment, and from July 4, 2026 eligible borrowers can combine 7(a) and 504 for up to $10 million in total program credit.
North Jersey practice values keep most acquisitions above the goodwill threshold that triggers an independent going-concern appraisal.
For a national view of this asset class, see our medical and dental practice SBA feasibility overview, and read our related analysis in the medical and dental practice lending research on our blog.
Compare neighboring markets: New Hampshire, New Mexico, Texas.
Public SBA and CDC program records, cited as program evidence
SBA 504 through PeopleFund
Medical office real estate purchase, national program evidence
Arlington, Tarrant County, Texas
Fifteen-minute scoping call, written proposal inside one business day, firm fixed fee before you sign.
Book a MeetingOur SBA feasibility study consultants prepare multifamily, mixed-use and residential development studies for lenders, CDCs and sponsors. See pricing, methodology or request a fixed fee quote.